A critical breakthrough in cancer research is arising with the use of VHH fragments to re-engage mutated p53. This vital tumor inhibitor protein is frequently inactivated in several forms of tumors, resulting https://single-bookmark.com/story21953483/nanobodies-revive-the-p53-protein-new-potential-hope-for-tumor-management